NCT00601354

Brief Summary

This study will evaluate the effectiveness of adding guided self-help group therapy to a weight loss program in achieving weight loss and reducing binge eating in overweight binge eaters.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
17

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2007

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2007

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

January 4, 2008

Completed
24 days until next milestone

First Posted

Study publicly available on registry

January 28, 2008

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2008

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2008

Completed
4.8 years until next milestone

Results Posted

Study results publicly available

September 9, 2013

Completed
Last Updated

September 9, 2013

Status Verified

June 1, 2013

Enrollment Period

1.2 years

First QC Date

January 4, 2008

Results QC Date

June 18, 2013

Last Update Submit

June 26, 2013

Conditions

Keywords

Binge EatingOrlistatAlliGuided Self-Help

Outcome Measures

Primary Outcomes (1)

  • Weight Loss

    Change in weight in lbs from per to post treatment

    3 months: Measured from pre to post treatment

Secondary Outcomes (1)

  • Binge Frequency

    3 months: Measured from pre to post treatment

Other Outcomes (1)

  • Weeks of Adherence to Orlistat

    Number of adherent weeks over 1 year study

Study Arms (2)

Emotion Regulation Group therapy + alli

EXPERIMENTAL

Group taking the weight loss medication orlistat (alli), in conjunction with the alli weight loss program, plus 12 weekly sessions of guided self-help group psychotherapy

Behavioral: Emotion regulation group therapyDrug: Orlistat/alli program

Orlistat/alli program meds only

ACTIVE COMPARATOR

Group taking the weight loss medication orlistat (alli), in conjunction with the alli weight loss program alone

Drug: Orlistat/alli program

Interventions

Emotion regulation guided self-help group therapy involves twelve 2-hour sessions of guided self-help group psychotherapy.

Also known as: emotion regulation guided self-help group therapy
Emotion Regulation Group therapy + alli

The orlistat/alli program involves taking 60 mg orlistat three times a day and participating in the alli program, a comprehensive behavioral weight loss program with online access.

Also known as: Alli
Emotion Regulation Group therapy + alliOrlistat/alli program meds only

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Body mass index greater than 27
  • Binge eating at least two times per week during the 6 months prior to study entry

You may not qualify if:

  • Current psychosis
  • Current suicidal ideations
  • Pregnant
  • Receiving concurrent psychotherapy
  • Unstable on psychotropic medications for 3 months prior to study entry

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stanford University School of Medicine

Stanford, California, 94305, United States

Location

MeSH Terms

Conditions

OverweightFeeding and Eating DisordersBulimia

Interventions

Orlistat

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsSigns and Symptoms, DigestiveMental DisordersHyperphagia

Intervention Hierarchy (Ancestors)

LactonesOrganic Chemicals

Results Point of Contact

Title
Dr. Debra L Safer
Organization
Stanford University

Study Officials

  • Debra L. Safer, MD

    Stanford University Department of Psychiatry

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PI

Study Record Dates

First Submitted

January 4, 2008

First Posted

January 28, 2008

Study Start

September 1, 2007

Primary Completion

November 1, 2008

Study Completion

December 1, 2008

Last Updated

September 9, 2013

Results First Posted

September 9, 2013

Record last verified: 2013-06

Locations